GV 2016, L.P.'s Net Worth
$280 Million
Who is GV 2016, L.P.?
GV 2016, L.P. has an estimated net worth of $280 Million. This is based on reported shares across multiple companies, which include IonQ, Inc., Magenta Therapeutics, Inc., Arcus Biosciences, Inc., ARMO BioSciences, Inc., Arsanis, Inc., Decibel Therapeutics, Inc., and Starco Brands, Inc..
SEC CIK
GV 2016, L.P.'s CIK is 0001721789
Past Insider Trading and Trends
2018 was GV 2016, L.P.'s most active year for acquiring shares with 3 total transactions. GV 2016, L.P.'s most active month to acquire stocks was the month of December. 2018 was GV 2016, L.P.'s most active year for disposing of shares, totalling 4 transactions. GV 2016, L.P.'s most active month to dispose stocks was the month of March. 2018 saw GV 2016, L.P. paying a total of $0.00 for 7,071,799 shares, this is the most they've acquired in one year. In 2022 GV 2016, L.P. cashed out on 3,186,822 shares for a total of $6,074,458.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IonQ, Inc. (IONQ) Snapshot price: $10.385
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.81% | -3.19M |
$11.16 | -$6,074,458.21 | 14.71M |
Apr 11
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $22.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.34M |
—
|
—
| 3.34M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arcus Biosciences, Inc. (RCUS) Snapshot price: $14.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.13M |
—
|
—
| 3.13M |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARMO BioSciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 607.35K |
—
|
—
| 607.35K |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arsanis, Inc. (XFOR) Snapshot price: $0.8548
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 451.36K |
—
|
—
| 451.36K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |